Filing Flows › NeuroPace (NPCE) › Q1 2026 › vs Q1 2025
NeuroPace (NPCE) Q1 2026 vs Q1 2025 (year over year)
NeuroPace's revenue fell $456K (-2%) from $22.5M in Q1 2025 to $22.1M in Q1 2026.
NeuroPace, Q1 2026: revenue $22.1M (-2% year over year), operating margin -25.2%, net loss $6.7M, operating cash flow −$5.9M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $22.1M | $22.5M | −$456K | -2% |
| Net loss | $6.7M | $6.6M | $100K | +2% |
| Costs & expenses | $28.8M | $29.1M | −$356K | -1% |
| Operating costs | $27.6M | $27.7M | −$35K | -0.1% |
| Interest & other, net | $1.1M | $1.4M | −$321K | -22% |
| Cost of revenue | $4.0M | $5.2M | −$1.2M | -22% |
| Research & development | $7.2M | $7.4M | −$251K | -3% |
| Sales & marketing | $11.6M | $11.0M | $580K | +5% |
| General & admin | $4.8M | $4.0M | $798K | +20% |
| Operating cash sources | $8.2M | $10.2M | −$1.9M | -19% |
| Depreciation | $60K | $49K | $11K | +22% |
| Share-based compensation | $2.3M | $2.6M | −$348K | -13% |
| Cash used in operations | $5.9M | $7.5M | −$1.6M | -21% |
| Net loss absorbed | $6.7M | $6.6M | $100K | +2% |
| Working capital & other | $1.5M | $3.6M | −$2.0M | -57% |
Questions
How much did NeuroPace's revenue grow year over year in Q1 2026?
NeuroPace's revenue fell $456K (-2%) from $22.5M in Q1 2025 to $22.1M in Q1 2026.